脊髓麻醉中氨甲环酸的灾难性用药错误
该综述通过MEDLINE检索1960至2018年间硬膜外或脊髓麻醉中给予氨甲环酸的病例,未发现硬膜外给药报告,共识别21例脊髓给药病例。20例发生危及生命的神经和/或心脏并发症需复苏和/或重症监护,10例死亡。所有错误均为技能型错误,可通过实施四项已发布的减少椎管内用药错误建议来预防。
要点
- 脊髓麻醉中误用氨甲环酸可导致灾难性神经和/或心脏并发症,死亡率高。
- 错误多为安瓿混淆等技能型错误,与组织政策、药品储存和准备等因素相关。
- 实施已发布的四项建议可预防此类错误。
核心结论
- 脊髓麻醉中误用氨甲环酸会导致危及生命的神经和/或心脏并发症,甚至死亡,但所有错误均可通过实施四项已发布的建议预防。
研究设计与样本
- 对MEDLINE数据库中1960至2018年间硬膜外或脊髓麻醉中给予氨甲环酸的病例进行综述,共识别21例脊髓给药病例。
主要发现
- 21例脊髓给药病例中,20例发生需复苏和/或重症监护的危及生命的神经和/或心脏并发症,10例死亡。
- 20例错误原因为安瓿错误,1例为脊髓导管被误认为静脉导管,所有错误均分类为技能型错误。
- 存在与组织政策、药品调配储存及脊髓麻醉任务准备相关的多种人为因素。
临床怎么用
- 应实施已发布的四项减少椎管内用药错误的建议,以预防氨甲环酸误用于脊髓麻醉。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We have reviewed accidental spinal administration of tranexamic acid. We performed a MEDLINE search of cases of administration of tranexamic acid during epidural or spinal anaesthesia between 1960 and 2018. No reports of epidural administration were identified. We identified 21 cases of spinal tranexamic acid administration. Life-threatening neurological and/or cardiac complications, requiring resuscitation and/or intensive care, occurred in 20 patients; 10 patients died. We used a Human Factors Analysis Classification System model to analyse any contributing factors, and the reports were also assessed using four published recommendations for the reduction in neuraxial drug error. In 20 cases, ampoule error was the cause; in the last case a spinal catheter was mistaken for an intravenous catheter. All were classified as skill-based errors. Several human factors related to organisational policy; dispensing and storage of drugs and preparation for spinal anaesthesia tasks were present. All errors could have been prevented by implementing the four published recommendations.
引用
- Patel S, Robertson B, McConachie I, et al. Catastrophic drug errors involving tranexamic acid administered during spinal anaesthesia. Anaesthesia. 2019. PMID: 30985928. doi:10.1111/anae.14662
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。